Elicio Therapeutics, Inc.ELTXNASDAQ

Revenue (LTM)

Net Income (LTM)

$-40M

+23.8% YoY

Free Cash Flow

$-37M

Revenue CAGR (5Y)

—

—Marginsstable

FCF($0.0B)

Unprofitable

Metric	Dec 21	Dec 22	Dec 23	Dec 24	Dec 25
Revenue	28	0	0	0	0
Gross Profit	27	-1↓103.9%	-1↓10.7%	-1↓0.7%	-1↑4.2%
Operating Income	-39	-24↑39.6%	-36↓50.6%	-45↓25.9%	-38↑16.2%
Net Income	-26	-28↓6.8%	-35↓24.8%	-52↓47.5%	-40↑23.8%
EBITDA	-52	-24↑54.6%	-33↓40.0%	-50↓52.5%	-37↑27.2%
EPS Diluted	-19.32	-9.10↑52.9%	-6.96↑23.5%	-4.25↑38.9%	-2.58↑39.3%

Metric	Dec 21	Dec 22	Dec 23	Dec 24	Dec 25
Cash & Equivalents	89	8↓91.2%	13↑65.4%	18↑36.6%	19↑5.4%
Total Current Assets	91	11↓88.3%	16↑52.5%	21↑26.6%	19↓6.7%
Total Assets	97	23↓76.5%	27↑19.8%	28↑3.8%	26↓8.2%
Total Current Liabilities	11	7↓39.2%	10↑42.0%	12↑18.1%	8↓29.6%
Total Liabilities	15	14↓8.4%	16↑14.7%	39↑150.4%	24↓38.7%
Total Equity	82	9↓89.1%	11↑27.6%	-11↓199.5%	2↑114.5%
Total Debt	5	7↑60.5%	7↓7.5%	26↑276.5%	15↓44.3%
Net Debt	-84	-0↑99.6%	-6↓1791.5%	8↑240.9%	-4↓148.1%

Metric	Dec 21	Dec 22	Dec 23	Dec 24	Dec 25
Operating Cash Flow	-24	-22↑7.4%	-33↓47.4%	-37↓13.4%	-37↑0.3%
Capital Expenditure	-1	-1↓24.5%	-0↑89.9%	-0↓31.8%	-0↑81.6%
Free Cash Flow	-24	-23↑6.7%	-33↓43.5%	-37↓13.4%	-37↑0.5%
Stock-Based Comp	1	1↓6.3%	1↑103.6%	1↑23.2%	3↑85.7%
Net Change in Cash	-5	-2↑67.8%	6↑460.9%	5↓11.8%	-0↓104.5%

Values in millions except EPS · Ratios shown as percentages · Click any metric to drill down

Explore More

Filter and sort all 500 stocks

Today's biggest gainers and losers

Visual sector performance